BioCentury
ARTICLE | Clinical News

Jalyn dutasteride/tamsulosin regulatory update

June 21, 2010 7:00 AM UTC

FDA approved an NDA from GlaxoSmithKline for Jalyn dutasteride/tamsulosin to treat symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. The company expects to launch the fi...